GlassScriptPhysician profile
Rene E Perez Rios
NPI 1053329532
$1,323.40
in general payments reported to CMS, 2019-2025
15 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $104 · 2021: $332 · 2022: $94.74 · 2023: $191 · 2024: $164 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $184.48 | 2019-2023 | Synergy, Opticross, Mamba |
| Astrazeneca Pharmaceuticals LP | $162.09 | 2019-2024 | Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.97 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $149.08 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.42 | 2021-2025 | Eliquis |
| Abbott Laboratories | $96.68 | 2019-2025 | Xience Skypoint, Diamondback Coronary |
| Chiesi USA, INC. | $91.25 | 2021 | |
| Medtronic Vascular, INC. | $73.56 | 2019-2020 | |
| Medtronic, INC. | $66.27 | 2021-2024 | Onyx Frontier |
| Amgen INC. | $62.78 | 2025 | Repatha, Repatha |
| Pbg Puerto Rico LLC | $60.72 | 2021-2025 | |
| Acist Medical Systems, INC. | $31.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.00 | 2024 | |
| Terumo Medical Corporation | $14.01 | 2020 | |
| Cardinal Health P.R. 120 INC | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Perez Rios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.